Wave Life Sciences WVE
NASDAQ WVE
$3.40 -0.02 (-0.58%)
As of: Nov 12, 2026 · 10:43 AM EST

Wave Life Sciences (WVE) Return on Sales [ROS] (2015 - 2026)

Updated

Wave Life Sciences (WVE) recorded Return on Sales [ROS] of -3248.33% in Q2 2026, down 2641.83 percentage points from -606.49% a year earlier and down 3166.49 percentage points from the prior quarter.

Analysis

Wave Life Sciences (WVE) Return on Sales [ROS] (2015 - 2026) Analysis & Trends

On a TTM basis, Wave Life Sciences' Return on Sales [ROS] came in at -333.36% as of Jun 30, 2026, down 202.06 percentage points year-over-year; for FY2025, it was -504.09%, down 402.15 percentage points from FY2024.

  • Annual Return on Sales [ROS] has a five-year change of +259.85 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Sales [ROS] came in at -101.94% in FY2024 (-41.93 pp), -60.01% in FY2023 (+4399.29 pp), -4459.30% in FY2022 (-4149.24 pp) and -310.07% in FY2021 (+453.88 pp).
  • The Q2 2026 figure is the lowest quarterly Return on Sales [ROS] since Q4 2022.
  • On a year-over-year basis, Return on Sales [ROS] rose in three of the last eight quarters, with an average year-over-year change of -486.31 percentage points.
  • Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 13657.80 percentage points in Q3 2023, against a drop of 13627.89 percentage points in Q3 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -81.83% (Q1 2026), -327.44% (Q4 2025) and -740.71% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Wave Life Sciences 672.50 Mn -1.27 Bn - -501.95%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -501.95%
Jun 30, 2026 -3,248.33%
Mar 31, 2026 -81.83%
Dec 31, 2025 -327.44%
Sep 30, 2025 -740.71%
Jun 30, 2025 -606.49%
Mar 31, 2025 -542.82%
Dec 31, 2024 27.42%
Sep 30, 2024 -832.66%
Jun 30, 2024 -177.72%
Mar 31, 2024 -274.83%
Dec 31, 2023 -64.30%
Sep 30, 2023 9.03%
Jun 30, 2023 -106.18%
Mar 31, 2023 -234.24%
Dec 31, 2022 -3,515.98%
Sep 30, 2022 -13,648.77%
Jun 30, 2022 -11,243.73%
Mar 31, 2022 -2,176.80%
Dec 31, 2021 -2,045.89%
API Access

Wave Life Sciences Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=WVE&period=max&api_key=YOUR_API_KEY